Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Enerisant (TS-091) is an orally active, selective and potent histamine H3 receptor antagonist that modulates histamine H3 receptors in mice in a dose-dependent manner.Enerisant promotes pro-cognitive effects and reverses scopolamine-induced cognitive deficits.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $44 | In Stock | |
| 2 mg | $65 | In Stock | |
| 5 mg | $109 | In Stock | |
| 10 mg | $178 | In Stock | |
| 25 mg | $377 | In Stock | |
| 50 mg | $487 | In Stock | |
| 100 mg | $678 | In Stock | |
| 200 mg | $918 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $119 | In Stock | 
| Description | Enerisant (TS-091) is an orally active, selective and potent histamine H3 receptor antagonist that modulates histamine H3 receptors in mice in a dose-dependent manner.Enerisant promotes pro-cognitive effects and reverses scopolamine-induced cognitive deficits.  | 
| Targets&IC50 |  H3 receptor (rat):7.87 nM, H3 receptor (human):1.65 nM(Ki), H3 receptor (rat):14.5 nM, H3 receptor (human):2.89 nM  | 
| In vivo | In the male SD rat model of R-α-methylhistamine-induced dipsogenia, Enerisant (oral, single dose, 0.1, 0.3, and 1 mg/kg) attenuated the dipsogenic response[1].  | 
| Synonyms | TS-091 | 
| Molecular Weight | 398.50 | 
| Formula | C22H30N4O3 | 
| Cas No. | 1152747-82-4 | 
| Smiles | C(=O)(C1=CN(N=C1)C2=CC=C(OCCCN3[C@H](C)CCC3)C=C2)N4CCOCC4 | 
| Relative Density. | no data available | 
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (200.75 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.28 mM), Sonication is recommended.  Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.